Loading quotes...
Forecast
There is no analyst data available for this company.
Discussions in the community
- 2 44
News Go to news feed
Savaria surpasses Q2 forecasts thanks to improved margins
Savaria reported adjusted earnings of CAD 0.35 per share and revenue of CAD 245.8m for Q2 2026, both slightly above estimates, with revenue up 8.4%. The adjusted EBITDA margin improved to 21.1%; the accessibility segment posted the strongest margin at 23.6%, while the patient care segment suffered from raw material costs. Management reaffirmed its target of roughly 12% annual revenue growth through 2030 and EBITDA margins above 20%, along with further investments and potential acquisitions. The stock rose moderately after the results and is trading near its 52-week high. » More on de.investing.com
Savaria beats Q1 2026 expectations for revenue and EPS, but stock falls
Savaria reported Q1 2026 revenue of CAD 235.5m (+7%) and EPS of CAD 0.31, both slightly above analyst estimates. Adjusted EBITDA rose 20.3% and gross margin improved to 38.9%, which is attributed to the Savaria One operational program. Despite the positive results, the stock fell 1.59% after the release; management remains optimistic and plans product launches in Europe and North America. The board and analysts see risks from currency fluctuations, market saturation in stairlifts and macroeconomic pressure. » More on de.investing.com
Savaria surpasses Q4 expectations with strong revenue and margin growth
Savaria reported Q4 EPS of CAD 0.37, well above the analyst estimate of CAD 0.3239, with revenue of CAD 241.8 million versus expected CAD 237.29 million. The adjusted EBITDA margin rose to a record 21.2% and adjusted EBITDA grew 20% year over year. The stock then climbed 4.03% to CAD 24.32; the company expects further growth from the "Savaria One" program as well as expansion in accessibility and patient care. » More on de.investing.com
Savaria: Q3 EBITDA margin above 20%, EPS beats expectations
Savaria reported Q3 2025 EPS of CAD 0.32, beating estimates by 5.3%, while revenue of CAD 224.8m was slightly below expectations. Net income rose 69% year-on-year to CAD 19.5m, gross margin improved to 39.2%, and adjusted EBITDA reached CAD 47.6m (21.2% margin). The stock rose 2.66% after the close. For 2025 Savaria forecasts full-year revenue of around CAD 925m and an adjusted EBITDA margin just above 20%, with a focus on expansion, product launches and an investor day in April 2026. » More on de.investing.com
Savaria announces monthly dividend of 4.67 cents per share
Savaria will pay a monthly dividend of 4.67 cents (US$0.0467) per common share, payable on November 12, 2025 to shareholders of record on October 31, 2025. The distribution is considered an eligible dividend under the Canadian Income Tax Act. Savaria, a manufacturer of accessibility solutions with a global presence, has a market capitalization of US$686.1 million and a gross profit margin of 52.59%. » More on de.investing.com
Historical dividends Dividends
All dividend metrics All metricsFinancials
| (EUR) | September 2026 | YoY |
|---|---|---|
| Revenue | 151.95m | 10.47% |
| Gross profit | 59.76m | 10.80% |
| Net profit | 14.3m | 19.99% |
| EBITDA | 30.2m | 15.59% |
Fundamentals
| Metric | Value |
|---|---|
Market capitalization | €1.38bn |
Number of shares | 72.27m |
52-week high/low | €20.26 - €13.14 |
Dividend yield | 1.87% |
Dividends TTM | €0.35 |
Beta | 0.97 |
P/E ratio | 23.61 |
PEG ratio | 0.48 |
P/B ratio | 3.11 |
P/S ratio | 2.26 |
Company profile
Savaria Corporation provides accessibility solutions for the elderly and physically challenged people in Canada, the United States, Europe, and internationally. The company operates in three segments: Accessibility, Patient Care, and Adapted Vehicles. The Accessibility segment designs, manufactures, distributes, and installs accessibility products, such as stairlifts for straight and curved stairs, vertical and inclined wheelchair platform lifts for commercial and residential applications, and accessibility and home elevators. The Patient Care segment manufactures and distributes therapeutic support surfaces and other pressure management products for the medical and medical beds, as well as offers medical equipment and solutions for the safe handling of patients. The Adapted Vehicles segment offers distributing vehicles for people with mobility challenges for personal or commercial use. The company sells its products through dealers and by direct stores to end-user customers. Savaria Corporation was founded in 1979 and is headquartered in Laval, Canada.
| Name | SAVARIA CORP. |
| CEO | Sebastien Bourassa |
| Headquarters | Laval,
qc Canada |
| Website | |
| IPO | 20/03/2003 |
| Employees | 2,600 |
Ticker symbols
| Exchange | Symbol |
|---|---|
Toronto Stock Exchange | SIS.TO |
Pnk | SISXF |
Frankfurt | S97.F |
Düsseldorf | S97.DU |
München | S97.MU |